Page last updated: 2024-08-17

quinidine and Encephalopathy, Traumatic

quinidine has been researched along with Encephalopathy, Traumatic in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Batty, R; Clay, FJ; Hicks, AJ; Hopwood, M; Jayaram, M; Perry, LA; Ponsford, JL	1
Nguyen, D; Young, FG	1
Davis, C; Formella, AE; Hammond, FM; Ledon, F; Sauve, W	1
Alexander, DN; Cutler, AJ; D'Amico, S; Davis, CS; Doody, RS; Formella, AE; Hammond, FM; Ledon, F; Sauve, W; Shin, P; Siffert, J; Yonan, C; Zorowitz, RD	1

Reviews

1 review(s) available for quinidine and Encephalopathy, Traumatic

Article	Year
Pharmacotherapy for the Pseudobulbar Affect in Individuals Who Have Sustained a Traumatic Brain Injury: a Systematic Review. Neuropsychology review, 2020, Volume: 30, Issue:1 Topics: Affective Symptoms; Brain Injuries, Traumatic; Dextromethorphan; Drug Combinations; Humans; Neurotransmitter Agents; Quinidine	2020

Trials

2 trial(s) available for quinidine and Encephalopathy, Traumatic

Article	Year
Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study. PM & R : the journal of injury, function, and rehabilitation, 2018, Volume: 10, Issue:10 Topics: Adult; Brain Injuries, Traumatic; Dextromethorphan; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injury Severity Score; Male; Maximum Tolerated Dose; Middle Aged; Neuropsychological Tests; Patient Safety; Patient Selection; Prognosis; Prospective Studies; Pseudobulbar Palsy; Quinidine; Risk Assessment; Severity of Illness Index; Treatment Outcome	2018
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC neurology, 2016, Jun-09, Volume: 16 Topics: Aged; Brain Injuries, Traumatic; Dementia; Dextromethorphan; Drug Administration Schedule; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Pseudobulbar Palsy; Quinidine; Severity of Illness Index; Stroke; Treatment Outcome	2016

Article

Year

Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study.

PM & R : the journal of injury, function, and rehabilitation, 2018, Volume: 10, Issue:10

Topics: Adult; Brain Injuries, Traumatic; Dextromethorphan; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injury Severity Score; Male; Maximum Tolerated Dose; Middle Aged; Neuropsychological Tests; Patient Safety; Patient Selection; Prognosis; Prospective Studies; Pseudobulbar Palsy; Quinidine; Risk Assessment; Severity of Illness Index; Treatment Outcome

2018

PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.

BMC neurology, 2016, Jun-09, Volume: 16

Topics: Aged; Brain Injuries, Traumatic; Dementia; Dextromethorphan; Drug Administration Schedule; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Pseudobulbar Palsy; Quinidine; Severity of Illness Index; Stroke; Treatment Outcome

2016

Other Studies

1 other study(ies) available for quinidine and Encephalopathy, Traumatic

Article	Year
Treatment of pseudobulbar affect (PBA) in a patient with a history of traumatic brain injury, partial brain resection, and brainstem stroke: a case report. Journal of medical case reports, 2020, Dec-04, Volume: 14, Issue:1 Topics: Brain; Brain Injuries, Traumatic; Brain Stem Infarctions; Dextromethorphan; Humans; Male; Middle Aged; Quinidine	2020